52w high/low | ₹169.8 / ₹54.45 |
P/E ratio | 196.76 |
Dividend | 0 |
ROE | 2.91 |
ROCE | 3.66 |
Face value | 10 |
Book value | ₹11.3Cr |
Market capital | ₹105.64Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Biofil Chemicals & Pharmaceuticals (BCPL) was incorporated as a private limited company on 4 Jan. '85 for manufacture of pharmaceutical products and it was converted into a public limited company on 7 May '92. It was promoted by the Systematix group and Ramesh Shah of the Cyano group. Ramesh Shah is the chairman and managing director and Anand Kumar Sethiya is the managing director. In Feb. '96, the company had come out with a rights-cum-public issue at a premium of Rs 7. 50 and at a premium of Rs 12. 50 respectively, both aggregating Rs 23.